Reynders McVeigh Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,974
Closed -$297K 212
2017
Q3
$297K Sell
4,974
-839
-14% -$49.9K 0.04% 170
2017
Q2
$377K Sell
5,813
-4,697
-45% -$297K 0.05% 160
2017
Q1
$656K Sell
10,510
-5,212
-33% -$314K 0.09% 124
2016
Q4
$908K Sell
15,722
-4,410
-22% -$261K 0.13% 105
2016
Q3
$1.2M Sell
20,132
-32,142
-61% -$1.97M 0.17% 87
2016
Q2
$3.24M Sell
52,274
-19,376
-27% -$1.19M 0.47% 42
2016
Q1
$4.42M Buy
+71,650
New +$4.22M 0.65% 38

Other funds holding XRAY

Reynders McVeigh Capital Management's XRAY Position: Q4 2017 in Review

Reynders McVeigh Capital Management sold out of Dentsply Sirona (XRAY) in Q4 2017, closing a stake of 4,974 shares — an estimated $297K sold.

Reynders McVeigh Capital Management first reported a position in XRAY in Q1 2016 and held it in 7 quarters. The position peaked at $4.42M in Q1 2016. 570 funds tracked by Wall St. Rank hold XRAY as of Q4 2017.

  • Reynders McVeigh Capital Management reported no remaining Dentsply Sirona position as of Q4 2017 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 4,974 Dentsply Sirona shares in Q4 2017, an estimated $297K.
  • Reynders McVeigh Capital Management first reported a position in Dentsply Sirona in Q1 2016 and held it in 7 quarters.
  • Reynders McVeigh Capital Management's Dentsply Sirona position peaked at $4.42M in Q1 2016.
  • 570 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2017.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2017, filed 6 Feb 2018.